Literature DB >> 10215946

Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.

R A Kadir1, D L Economides, C A Sabin, D Pollard, C A Lee.   

Abstract

Menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders were assessed in this study. One hundred and sixteen women, including 66 with von Willebrand's disease (vWD), 30 carriers of haemophilia and 20 with factor XI (FXI) deficiency were interviewed and their gynaecological history obtained. Their case records were also reviewed and menstrual loss was objectively assessed using a pictorial blood assessment chart (PBAC). Comparison with an age-matched control group (69 women) was performed. Menorrhagia (PBAC score> 100) was confirmed in 74%, 57% and 59% of women with vWD, carriers of haemophilia and FXI deficiency, respectively, in comparison with 29% in the control group (P = 0.001). PBAC scores were higher in vWD patients with a von Willebrand factor activity (vWF:Ac) of </= 30 IU dL-1 compared to those with higher levels, but the difference was not statistically significant. However, there was no relation between PBAC score and the severity of the disease in FXI deficient patients and carriers of haemophilia. Duration of menstruation was significantly longer (P = 0.001) and episodes of flooding was significantly more common (P = 0.001) in patients with inherited bleeding disorders compared to the control group. However, there was no difference in the passage of clots during menstruation. Forty-seven per cent of patients with inherited bleeding disorders had consultations with their family practitioner or gynaecologist for menorrhagia, 36% had medical treatment and 27% had surgical procedures, including 10 hysterectomies. Post-operative bleeding followed in four out of 28 cases of hysteroscopy and/or dilatation and curettage. Bleeding complications following hysterectomy were reported in five out of 10 patients. In conclusion, menorrhagia is a common and major problem in patients with inherited bleeding disorders, especially vWD. Increased awareness among gynaecologists and haematologists of the high prevalence of menorrhagia and the treatment options available is necessary for optimal management of these patients. Appropriate preoperative assessment and haemostatic control during any gynaecological procedure, however minor, and in collaboration with the local haemophilia centre is essential to minimize risks of haemorrhagic complications.

Entities:  

Mesh:

Year:  1999        PMID: 10215946     DOI: 10.1046/j.1365-2516.1999.00285.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  14 in total

1.  Haemophilia A carriers experience reduced health-related quality of life.

Authors:  L Gilbert; A Paroskie; D Gailani; M R Debaun; R F Sidonio
Journal:  Haemophilia       Date:  2015-04-30       Impact factor: 4.287

2.  Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study.

Authors:  Joline L Saes; Marieke J A Verhagen; Karina Meijer; Marjon H Cnossen; Roger E G Schutgens; Marjolein Peters; Laurens Nieuwenhuizen; Felix J M van der Meer; Ilmar C Kruis; Waander L van Heerde; Saskia E M Schols
Journal:  Blood Adv       Date:  2020-10-27

3.  Uptake of Genetic Counseling, Knowledge of Bleeding risks and Psychosocial Impact in a South African Cohort of Female Relatives of People with Hemophilia.

Authors:  Anne Gillham; Brenda Greyling; Tina-Marie Wessels; Bongi Mbele; Rosemarie Schwyzer; Amanda Krause; Johnny Mahlangu
Journal:  J Genet Couns       Date:  2015-04-02       Impact factor: 2.537

4.  Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.

Authors:  V R Byams; P A Kouides; R Kulkarni; J R Baker; D L Brown; J C Gill; A M Grant; A H James; B A Konkle; J Maahs; M M Dumas; S McAlister; D Nance; D Nugent; C S Philipp; J M Soucie; E Stang
Journal:  Haemophilia       Date:  2011-07       Impact factor: 4.287

5.  Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.

Authors:  Misha Khalighi; Allison P Wheeler; Oluyemisi A Adeyemi-Fowode; Peter A Kouides; Ramon A Durazo-Arvizu; Kristina Haley; Candice M Dersch; Angela C Weyand; Maureen K Baldwin; Claudia Borzutzky
Journal:  J Adolesc Health       Date:  2022-04-13       Impact factor: 7.830

6.  Complications of hysterectomy in women with von Willebrand disease.

Authors:  A H James; E R Myers; C Cook; R Pietrobon
Journal:  Haemophilia       Date:  2009-04-07       Impact factor: 4.287

7.  Significant gynecological bleeding in women with low von Willebrand factor levels.

Authors:  Michelle Lavin; Sonia Aguila; Niall Dalton; Margaret Nolan; Mary Byrne; Kevin Ryan; Barry White; Niamh M O'Connell; Jamie M O'Sullivan; Jorge Di Paola; Paula D James; James S O'Donnell
Journal:  Blood Adv       Date:  2018-07-24

Review 8.  Endometrial haemostasis and menstruation.

Authors:  Joanna Davies; Rezan A Kadir
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

9.  Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease.

Authors:  Megan C Brown; Michael H White; Rachel Friedberg; Kalinda Woods; Krista Childress; Mona Kulkarni; Robert F Sidonio
Journal:  Res Pract Thromb Haemost       Date:  2021-05-04

10.  Clinical and laboratory characteristics of adolescents with platelet function disorders and heavy menstrual bleeding.

Authors:  Lawrence S Amesse; Teresa Pfaff-Amesse; William T Gunning; Nancy Duffy; James A French
Journal:  Exp Hematol Oncol       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.